Featured

  • Medical News
A new study provides reassuring information about the short-term and long-term safety of denosumab, a monoclonal antibody that is used to treat postmenopausal osteoporosis.Adverse events that had
News
Astonishing Monsters - Apocalypse according ... Francesco Carelli - University Milan, Rome The Italian ... (19 Mar 2017)
Denosumab Found Safe in Long-Term Trial A new study provides reassuring information about the short-term ... (21 Mar 2017)
Rivaroxaban Reduces VTE Recurrence Compared ... In patients at elevated risk for a recurrence of potentially ... (21 Mar 2017)
Lifestyle Intervention Leads to 10-point ... In the first randomized, double-blinded trial of an online ... (21 Mar 2017)
Study Shows Benefits to Treating All Clogged ... Patients experiencing a major heart attack often have more than ... (21 Mar 2017)

Associates

0
0
0
0
0
0

SPONSOR MESSAGE

Join us

Get Social

 

News Roundup

Hide Main content block

Links

Join

Connect with other Medical Professionals on fb in a closed facebook group

Login

Template Settings

Theme Colors

Cyan Red Green Oranges Teal

Layout

Wide Boxed Framed Rounded
Patterns for Layour: Boxed, Framed, Rounded
Top
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…